Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

The repositioning or “repurposing” of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed therapies is on efficacy, with less restricti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, J. Javier, Pryszlak, Michael, Smith, Lindsay, Yanchus, Connor, Kurji, Naheed, Shahani, Vijay M., Molinski, Steven V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694537/
https://www.ncbi.nlm.nih.gov/pubmed/29184849
http://dx.doi.org/10.3389/fonc.2017.00273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694537/
https://www.ncbi.nlm.nih.gov/pubmed/29184849
http://dx.doi.org/10.3389/fonc.2017.00273

Ejemplares similares